The Speaker Spotlight – 2016 National Conference Edition Part 3

1932335_1378352615810163_5157688386607314760_n

Hal Gerstein, MD

Medical Director, Medical Oncology, Hematology and Immunology, Cancer Institute of Long Island

imageedit_3_4275400035

Bio:

Dr. Hal Gerstein was a member of the exclusive Biomedical Research Program at the Rensselaer Polytechnic Institute in Troy, NY and the Albany Medical College in Albany, NY where he earned both a Bachelor of Science degree and a Doctor of Medicine degree in 1978 after six years of study. While earning his degree, Dr. Gerstein was awarded the Mosby Award for Outstanding Research in the field of virology. He then successfully completed an internal medicine residency as well as a medical oncology and hematology fellowship at the North Shore University Hospital and Memorial Sloan-Kettering Hospital from 1978 through 1984. Dr. Gerstein is board-certified in both  Internal Medicine and Medical Oncology by the American Board of Internal Medicine.

Dr. Gerstein is currently a Senior Attending Physician on the staff of both the North Shore University Hospital in Manhasset and the Long Island Jewish Hospital in New Hyde Park. He has held teaching positions at the NYU School of Medicine and the Cornell School of Medicine, and is currently the medical advisor to the Neuroendocrine Cancer Awareness Network.  Dr. Gerstein has participated in over twenty research projects in the field of medical oncology as a principle investigator and has published several papers in nationally recognized journals. He brings over 30 years of clinical expertise to his patients.

To make an appointment, please call:

Cancer Institute of Long Island
225 Community Drive, Suite 160                                                                                         Great Neck, NY 11021                                                                                                               516-482-4790

Dr. Gerstein at the 2016 National NET Patient Conference:

Topic: Poorly Differentiated & Undifferentiated NETs: What’s our approach to these cases?

When: Friday, September 23rd, 2016 at 3:30PM*

Be sure not to miss Dr. Gerstein speak! And don’t miss him on our panel answering your questions!!

For more information on Dr. Gerstein and the Cancer Institute of Long Island, please visit their website here.

SIGN UP NOW FOR THE 2016 NATIONAL NET PATIENT CONFERENCE in New Orleans, LA from September 22-24th to see Dr. Gerstein and 19 other experts speak on Neuroendocrine Cancer! 

Registration is $125 per person including

  • Thursday’s Welcome Reception 
  • Breakfast, Lunch, and snacks for both Friday and Saturday
  • And keep your eyes out for some special prizes!

Registration does not include your hotel stay or travel expenses.

For more information and to buy your ticket, click here!!

*Time and Date are subject to change.

Be sure to check out our Speaker Spotlight on Dr. Ed Wolin and Dr. Robert Ramirez!

The Speaker Spotlight – 2016 National Conference Edition Part 2

drramirez

Robert Ramirez, DO, FACP

oschnermedcenterlogo

Bio:

Dr. Ramirez earned his medical degree from the University of Medicine and Dentistry of New Jersey School of Osteopathic Medicine.  He completed an internal medicine residency at Cooper University Hospital in Camden, New Jersey.  He then completed a combined hematology and medical oncology fellowship at the University of Tennessee Health Sciences Center in Memphis, Tennessee where he served as chief fellow.   He is board certified in medical oncology and internal medicine.  He is a Fellow of the American College of Physicians (FACP) and a member of American Society of Clinical Oncology (ASCO), International Association for the Study of Lung Cancer (IASLC), and the North American Neuroendocrine Tumor Society (NANETS). 

He has clinical and research interests in lung cancer, specifically non-small cell and small cell cancers as well as neuroendocrine tumors of the lung including DIPNECH, typical and atypical carcinoids.  He has given multiple presentations at National and International meetings on the topics of lung cancer and neuroendocrine tumors and has multiple peer reviewed publications.  He is a recognized thought leader in these fields. He splits his clinical and research duties between the Ochsner Lung Cancer Multidisciplinary Program and the Ochsner Kenner/LSU Multidisciplinary Neuroendocrine Clinic.  He is active in clinical trial design as well as teaching to fellows, residents and medical students.  

Dr. Ramirez’s clinical interests include: Non-small cell lung cancer, small cell lung cancer, neuroendocrine tumors of the lung, DIPNECH and neuroendocrine tumors of the GI tract.

To make an appointment, please contact Pam Ryan, RN:

NOLANETS-New Orleans Louisiana Neuroendocrine Tumor Specialists                  200 West Esplanade, Ste. 200                                                                                        Kenner, LA 70065                                                                                                                    (504) 464-8500                                                                                                                               or toll free: (866) 91-ZEBRA

For more information on the NOLANETS Group and Dr. Robert Ramirez, please visit their website here.

Dr. Ramirez at the 2016 National NET Patient Conference:

Topic: LungNETs and DIPNECH: Diagnosis and Therapy

When: Friday, September 23rd, 2016 at 3PM*

Note on topic from Dr. Ramirez:

“I am slated to give an overview of neuroendocrine tumors of the lung.  I have a particular interest in lung cancer and specifically all forms of neuroendocrine lung tumors ranging from DIPNECH to small cell.  This is an under represented portion of neuroendocrine tumors not only in research but in general awareness.”

SIGN UP NOW FOR THE 2016 NATIONAL NET PATIENT CONFERENCE in New Orleans, LA from September 22-24th to see Dr. Ramirez and 19 other experts speak on Neuroendocrine Cancer! 

Registration is $125 per person including

  • Thursday’s Welcome Reception 
  • Breakfast, Lunch, and snacks for both Friday and Saturday
  • And keep your eyes out for some special prizes!

Registration does not include your hotel stay or travel expenses.

For more information and to buy your ticket, click here!!

*Time and Date are subject to change.

You can also see Dr. Ramirez speak about the Basics of Lung Neuroendocrine at the 2016 LungNET Conference on Saturday, June 11th, 2016 in Denver, CO!!

Registration for the 2016 LungNET Conference is $25 per person and includes breakfast, lunch, and snacks!

Registration does not include your hotel stay or travel expenses.

For more information and to buy your ticket to the 2016 LungNET Conference, click here!

Want the chance to see BOTH amazing conferences? Sign up NOW to get FREE registration for the 2016 LungNET Conference when you register for the 2016 National NET Patient Conference. SEE HOW TO GET FREE REGISTRATION TO THE 2016 LUNGNET CONFERENCE!

Be sure to check out our Speaker Spotlight on Dr. Ed Wolin!

The Speaker Spotlight – 2016 National Conference Edition

Welcome to the NETCancerAwarenessBlog’s first of the Speaker Spotlight Series-2016 National Conference Edition!!

drwolin

Edward M. Wolin, MD

Director, Neuroendocrine Tumor Program, Montefiore Einstein Center for Cancer Care

Montefiore

Department: Oncology

Bio:

Edward M. Wolin, MD is an internationally recognized Neuroendocrine Medical Oncologist. Patients from all over the United States and abroad come to see him for access to personalized care and the latest diagnostic and therapy programs.   

Dr. Wolin graduated from Reed College in Portland, Oregon, and received his MD degree From Yale School of Medicine at Yale University in New Haven, Connecticut.  After serving as intern and resident in Internal Medicine at Stanford University, he became a clinical fellow at the National Cancer Institute in Bethesda, Maryland.  He returned to Stanford to complete his Fellowship in Medical Oncology before starting his academic career at the faculty of Washington University School of Medicine in St. Louis, Missouri.

Dr. Wolin was previously the Director of Neuroendocrine and GI Oncology Program and the Director of Clinical Research at the University of Kentucky Medical Center.  For the preceding 26 years, he held key positions at Cedars–Sinai Medical Center in Los Angeles, where he founded and directed of one of the largest and most productive Carcinoid and Neuroendocrine Tumor Programs in the country.

Clinical Focus:

Dr. Wolin treats all types of carcinoid and neuroendocrine tumors, ranging from tumors of the small intestine (carcinoid), pancreas, lung and colon to those of the rectum, appendix, stomach and other sites. These include hormone-producing tumors such as carcinoid (serotonin), gastrinoma (gastrin), insulinoma (insulin), glucagonoma (glucagon), VIPoma (VIP); liver metastasis, and carcinoid syndrome. 

Dr. Wolin is a critical member of Montefiore’s outstanding multidisciplinary neuroendocrine team, that includes medical oncologists, surgeons, gastroenterologists, endocrinologists, as well as specialists in nuclear medicine, interventional radiology, diagnostic radiology, and other areas.

Research Focus:

As Director of the Neuroendocrine Tumor Program at Montefiore Einstein Center for Cancer Care, Dr. Wolin brings a robust research program to Montefiore that supports multiple clinical trials. His research efforts focus on finding the most effective and least toxic treatments, such as pasireotide, lanreotide, everolimus, other m-TOR inhibitors, targeted radiation, including peptide receptor radiotherapy with Lu-177.

Dr. Wolin has pioneered the development of neuroendocrine tumor therapy with novel somatostatin analogs, mTOR inhibitors, anti-angiogenic drugs, and peptide receptor radiotherapy (PRRT) using 177Lu-DOTATATE, as well as PET imaging with 67GA-DOTATATE scanning.

His research also pursues new directions in immunotherapy, anti-angiogenic drugs, novel targeted biologic anti-cancer treatments, as well as targeted treatment of liver metastases. In addition, Dr. Wolin directs his research towards the development of new imaging and diagnostic procedures for carcinoid/neuroendocrine tumors.

To make an appointment, please call:

Montefiore M-E Center for Cancer Center                                                                         1521 Jarrett Place                                                                                                                  Bronx, NY 10461-2601                                                                                                            (718) 862-8840

Dr. Wolin at the 2016 National NET Patient Conference:

Topic: The Role of Chemotherapy in Well-Differenciated NETs

When: Friday, September 23, 2016 at 2PM*

Be sure not to miss Dr. Wolin speak! And don’t miss him on our panel answering your questions!!

For additional info on Dr. Ed Wolin, please see his profile here.

If you would like to read some of Dr. Wolin’s pulications on PubMed, you can do so here.

SIGN UP NOW FOR THE 2016 NATIONAL NET PATIENT CONFERENCE in New Orleans, LA from September 22-24th to see Dr. Wolin and 19 other experts speak on Neuroendocrine Cancer! 

Registration is $125 per person including

  • Thursday’s Welcome Reception 
  • Breakfast, Lunch, and snacks for both Friday and Saturday
  • And keep your eyes out for some special prizes!

Registration does not include your hotel stay or travel expenses.

For more information and to buy your ticket, click here!!

*Time and Date are subject to change.

Introducing the Speaker Spotlight series!

TheSpeakerSpotlight

Starting this week, I will be introducing you to the speakers of NCAN’s upcoming events in a new series, Speaker Spotlight. Speaker Spotlight will be ongoing for all future events.

This series will be used to:

  • Give you backround information on who the presenter is,
  • An introduction to the topic they are presenting on,
  • and how to set up an appointment or contact them.

Also, I will be periodically including Q&As with the speakers themselves or blurbs of information directly from them and get them involved!

Be sure to follow the NETCancerAwarenessBlog so you don’t miss out!

You can find NETCancerAwarenessBlog on Facebook and Twitter!!